LifeCycle Pharma A/S - Report Pursuant to the Danish Securities Trading Act, Section 28(a)

Company Announcement no. 6/2010

To: NASDAQ OMX Copenhagen		Hørsholm, Denmark, April 7, 2010


LifeCycle Pharma A/S - Report Pursuant to the Danish Securities Trading Act,
Section 28(a) 

Hørsholm, Denmark, April 7, 2010; Pursuant to the Danish Securities Trading
Act, Section 28(a), LifeCycle Pharma A/S (OMX: LCP) is required on a daily
basis, to make public transactions in LifeCycle Pharma shares and related
securities by persons discharging managerial responsibilities and persons /
companies closely associated with these. 

Name	                    Timothy C. Melkus
Reason for reporting	Senior Vice President, Development Operations
Issuer and ID code/ISIN	LifeCycle Pharma A/S / DK0060048148
Type of transaction	         Purchase of shares
Date of transaction	         April 6, 2010
Relevant market	         NASDAQ OMX Copenhagen
Number of traded securities	 100,000
Market value	          DKK 535,000

For more information, please contact: 
LifeCycle Pharma A/S
Peter Schøtt Knudsen
Head of Investor Relations 
Phone: + 45 2055 3817
Email: PSK@lcpharma.com